TY - JOUR AU - Northrup, H. AU - Krueger, D. A. PY - 2013 DA - 2013// TI - Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International tuberous sclerosis complex consensus conference JO - Pediatr Neurol VL - 49 UR - https://doi.org/10.1016/j.pediatrneurol.2013.08.001 DO - 10.1016/j.pediatrneurol.2013.08.001 ID - Northrup2013 ER - TY - JOUR AU - Crino, P. B. AU - Nathanson, K. L. AU - Henske, E. P. PY - 2006 DA - 2006// TI - The tuberous sclerosis complex JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMra055323 DO - 10.1056/NEJMra055323 ID - Crino2006 ER - TY - JOUR AU - Baskin, H. J. PY - 2008 DA - 2008// TI - The pathogenesis and imaging of the tuberous sclerosis complex JO - Pediatr Radiol VL - 38 UR - https://doi.org/10.1007/s00247-008-0832-y DO - 10.1007/s00247-008-0832-y ID - Baskin2008 ER - TY - JOUR AU - Kopp, C. M. AU - Muzykewicz, D. A. AU - Staley, B. A. AU - Thiele, E. A. AU - Pulsifer, M. B. PY - 2008 DA - 2008// TI - Behavior problems in children with tuberous sclerosis complex and parental stress JO - Epilepsy Behav VL - 13 UR - https://doi.org/10.1016/j.yebeh.2008.05.010 DO - 10.1016/j.yebeh.2008.05.010 ID - Kopp2008 ER - TY - JOUR AU - Kwiatkowski, D. J. AU - Manning, B. D. PY - 2005 DA - 2005// TI - Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways JO - Hum Mol Genet VL - 14 Spec No. 2 UR - https://doi.org/10.1093/hmg/ddi260 DO - 10.1093/hmg/ddi260 ID - Kwiatkowski2005 ER - TY - JOUR AU - Wong, M. PY - 2008 DA - 2008// TI - Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation JO - Epilepsia VL - 49 UR - https://doi.org/10.1111/j.1528-1167.2007.01270.x DO - 10.1111/j.1528-1167.2007.01270.x ID - Wong2008 ER - TY - JOUR AU - Major, P. AU - Rakowski, S. AU - Simon, M. V. AU - Cheng, M. L. AU - Eskandar, E. AU - Baron, J. PY - 2009 DA - 2009// TI - Are cortical tubers epileptogenic? Evidence from electrocorticography JO - Epilepsia VL - 50 UR - https://doi.org/10.1111/j.1528-1167.2008.01814.x DO - 10.1111/j.1528-1167.2008.01814.x ID - Major2009 ER - TY - JOUR AU - Goh, S. AU - Butler, W. AU - Thiele, E. A. PY - 2004 DA - 2004// TI - Subependymal giant cell tumors in tuberous sclerosis complex JO - Neurology VL - 63 UR - https://doi.org/10.1212/01.WNL.0000142039.14522.1A DO - 10.1212/01.WNL.0000142039.14522.1A ID - Goh2004 ER - TY - JOUR AU - Franz, D. N. PY - 2004 DA - 2004// TI - Non-neurologic manifestations of tuberous sclerosis complex JO - J Child Neurol VL - 19 ID - Franz2004 ER - TY - JOUR AU - Johnson, S. R. PY - 2006 DA - 2006// TI - Lymphangioleiomyomatosis JO - Eur Respir J VL - 27 ID - Johnson2006 ER - TY - JOUR AU - Yates, J. R. PY - 2006 DA - 2006// TI - Tuberous sclerosis JO - Eur J Hum Genet VL - 14 UR - https://doi.org/10.1038/sj.ejhg.5201625 DO - 10.1038/sj.ejhg.5201625 ID - Yates2006 ER - TY - JOUR AU - Bhaskar, P. T. AU - Hay, N. PY - 2007 DA - 2007// TI - The two TORCs and Akt JO - Dev Cell VL - 12 UR - https://doi.org/10.1016/j.devcel.2007.03.020 DO - 10.1016/j.devcel.2007.03.020 ID - Bhaskar2007 ER - TY - JOUR AU - Franz, D. N. AU - Weiss, B. D. PY - 2012 DA - 2012// TI - Molecular therapies for tuberous sclerosis and neurofibromatosis JO - Curr Neurol Neurosci Rep VL - 12 UR - https://doi.org/10.1007/s11910-012-0269-4 DO - 10.1007/s11910-012-0269-4 ID - Franz2012 ER - TY - JOUR AU - Gao, X. AU - Pan, D. PY - 2001 DA - 2001// TI - TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth JO - Genes Dev VL - 15 UR - https://doi.org/10.1101/gad.901101 DO - 10.1101/gad.901101 ID - Gao2001 ER - TY - JOUR AU - Goncharova, E. A. AU - Goncharov, D. A. AU - Eszterhas, A. AU - Hunter, D. S. AU - Glassberg, M. K. AU - Yeung, R. S. PY - 2002 DA - 2002// TI - Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM) JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M202678200 DO - 10.1074/jbc.M202678200 ID - Goncharova2002 ER - TY - JOUR AU - Inoki, K. AU - Li, Y. AU - Zhu, T. AU - Wu, J. AU - Guan, K. L. PY - 2002 DA - 2002// TI - TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling JO - Nat Cell Biol VL - 4 UR - https://doi.org/10.1038/ncb839 DO - 10.1038/ncb839 ID - Inoki2002 ER - TY - JOUR AU - Kwiatkowski, D. J. AU - Zhang, H. AU - Bandura, J. L. AU - Heiberger, K. M. AU - Glogauer, M. AU - el-Hashemite, N. PY - 2002 DA - 2002// TI - A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells JO - Hum Mol Genet VL - 11 UR - https://doi.org/10.1093/hmg/11.5.525 DO - 10.1093/hmg/11.5.525 ID - Kwiatkowski2002 ER - TY - JOUR AU - Manning, B. D. AU - Tee, A. R. AU - Logsdon, M. N. AU - Blenis, J. AU - Cantley, L. C. PY - 2002 DA - 2002// TI - Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway JO - Mol Cell VL - 10 UR - https://doi.org/10.1016/S1097-2765(02)00568-3 DO - 10.1016/S1097-2765(02)00568-3 ID - Manning2002 ER - TY - JOUR AU - Potter, C. J. AU - Pedraza, L. G. AU - Xu, T. PY - 2002 DA - 2002// TI - Akt regulates growth by directly phosphorylating Tsc2 JO - Nat Cell Biol VL - 4 UR - https://doi.org/10.1038/ncb840 DO - 10.1038/ncb840 ID - Potter2002 ER - TY - JOUR AU - Ballou, L. M. AU - Lin, R. Z. PY - 2008 DA - 2008// TI - Rapamycin and mTOR kinase inhibitors JO - J Chem Biol VL - 1 UR - https://doi.org/10.1007/s12154-008-0003-5 DO - 10.1007/s12154-008-0003-5 ID - Ballou2008 ER - TY - BOOK PY - 2013 DA - 2013// TI - RxList: The internet drug index ID - ref21 ER - TY - JOUR AU - Ehninger, D. AU - Silva, A. J. PY - 2011 DA - 2011// TI - Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders JO - Trends Mol Med VL - 17 UR - https://doi.org/10.1016/j.molmed.2010.10.002 DO - 10.1016/j.molmed.2010.10.002 ID - Ehninger2011 ER - TY - JOUR AU - Lee, L. AU - Sudentas, P. AU - Donohue, B. AU - Asrican, K. AU - Worku, A. AU - Walker, V. PY - 2005 DA - 2005// TI - Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models JO - Gene Chromosome Cancer VL - 42 UR - https://doi.org/10.1002/gcc.20118 DO - 10.1002/gcc.20118 ID - Lee2005 ER - TY - JOUR AU - Fischer, L. AU - Saliba, F. AU - Kaiser, G. M. AU - Carlis, L. AU - Metselaar, H. J. AU - Simone, P. PY - 2015 DA - 2015// TI - Three-year outcomes in de novo liver transplant patients receiving everolimus with reduced tacrolimus: follow-up results from a randomized, multicenter study JO - Transplantation VL - 99 UR - https://doi.org/10.1097/TP.0000000000000555 DO - 10.1097/TP.0000000000000555 ID - Fischer2015 ER - TY - JOUR AU - Ribichini, F. AU - Romano, M. AU - Rosiello, R. AU - Vecchia, L. AU - Cabianca, E. AU - Caramanno, G. PY - 2013 DA - 2013// TI - A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease) JO - JACC Cardiovasc Interv VL - 6 UR - https://doi.org/10.1016/j.jcin.2013.05.016 DO - 10.1016/j.jcin.2013.05.016 ID - Ribichini2013 ER - TY - JOUR AU - Alfonso, F. AU - Perez-Vizcayno, M. J. AU - Cardenas, A. AU - Garcia Del Blanco, B. AU - Garcia-Touchard, A. AU - Lopez-Minguez, J. R. PY - 2015 DA - 2015// TI - A prospective randomized trial of drug-eluting balloons versus Everolimus-Eluting stents in patients with in-stent restenosis of drug-eluting stents: the ribs IV randomized clinical trial JO - J Am Coll Cardiol VL - 66 UR - https://doi.org/10.1016/j.jacc.2015.04.063 DO - 10.1016/j.jacc.2015.04.063 ID - Alfonso2015 ER - TY - JOUR AU - Motzer, R. J. AU - Escudier, B. AU - Oudard, S. AU - Hutson, T. E. AU - Porta, C. AU - Bracarda, S. PY - 2010 DA - 2010// TI - Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.25219 DO - 10.1002/cncr.25219 ID - Motzer2010 ER - TY - JOUR AU - Ravaud, A. AU - Barrios, C. H. AU - Alekseev, B. AU - Tay, M. H. AU - Agarwala, S. S. AU - Yalcin, S. PY - 2015 DA - 2015// TI - RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon alpha-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma JO - Ann Oncol VL - 26 ID - Ravaud2015 ER - TY - JOUR AU - Castellano, D. AU - Bajetta, E. AU - Panneerselvam, A. AU - Saletan, S. AU - Kocha, W. AU - O’Dorisio, T. PY - 2013 DA - 2013// TI - Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study JO - Oncologist VL - 18 UR - https://doi.org/10.1634/theoncologist.2012-0263 DO - 10.1634/theoncologist.2012-0263 ID - Castellano2013 ER - TY - JOUR AU - Pavel, M. E. AU - Hainsworth, J. D. AU - Baudin, E. AU - Peeters, M. AU - Horsch, D. AU - Winkler, R. E. PY - 2011 DA - 2011// TI - Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study JO - Lancet VL - 378 UR - https://doi.org/10.1016/S0140-6736(11)61742-X DO - 10.1016/S0140-6736(11)61742-X ID - Pavel2011 ER - TY - JOUR AU - Qiao, L. AU - Liang, Y. AU - Mira, R. R. AU - Lu, Y. AU - Gu, J. AU - Zheng, Q. PY - 2014 DA - 2014// TI - Mammalian target of rapamycin (mTOR) inhibitors and combined chemotherapy in breast cancer: a meta-analysis of randomized controlled trials JO - Int J Clin Exp Med VL - 7 ID - Qiao2014 ER - TY - STD TI - Sasongko TH IN, Nik Abdul Malik NMA, Zabidi-Hussin ZAMH. Rapamycin and its analogues (rapalogs) for tuberous sclerosis complex (Protocol). Cochrane Database Syst Rev 2014 (9). doi:10.1002/14651858.CD011272.pub2. ID - ref32 ER - TY - JOUR AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. AU - Altman, D. G. PY - 2009 DA - 2009// TI - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - PLoS Med VL - 6 UR - https://doi.org/10.1371/journal.pmed.1000097 DO - 10.1371/journal.pmed.1000097 ID - Moher2009 ER - TY - STD TI - Higgins JPT GSe. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. ID - ref34 ER - TY - STD TI - Review Manager (RevMan) [Computer Program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ID - ref35 ER - TY - STD TI - Wells GA Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Ottawa Hospital Research Institute. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 1 May 2015 UR - http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp ID - ref36 ER - TY - JOUR AU - Higgins, J. P. AU - Thompson, S. G. AU - Deeks, J. J. AU - Altman, D. G. PY - 2003 DA - 2003// TI - Measuring inconsistency in meta-analyses JO - BMJ VL - 327 UR - https://doi.org/10.1136/bmj.327.7414.557 DO - 10.1136/bmj.327.7414.557 ID - Higgins2003 ER - TY - JOUR AU - Herry, I. AU - Neukirch, C. AU - Debray, M. P. AU - Mignon, F. AU - Crestani, B. PY - 2007 DA - 2007// TI - Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex JO - Eur J Intern Med VL - 18 UR - https://doi.org/10.1016/j.ejim.2006.07.017 DO - 10.1016/j.ejim.2006.07.017 ID - Herry2007 ER - TY - JOUR AU - Peces, R. AU - Peces, C. AU - Cuesta-Lopez, E. AU - Perez-Duenas, V. AU - Vega-Cabrera, C. AU - Azorin, S. PY - 2010 DA - 2010// TI - Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex JO - Nephrol Dial Transplant VL - 25 UR - https://doi.org/10.1093/ndt/gfq456 DO - 10.1093/ndt/gfq456 ID - Peces2010 ER - TY - JOUR AU - Bissler, J. J. AU - McCormack, F. X. AU - Young, L. R. AU - Elwing, J. M. AU - Chuck, G. AU - Leonard, J. M. PY - 2008 DA - 2008// TI - Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMoa063564 DO - 10.1056/NEJMoa063564 ID - Bissler2008 ER - TY - JOUR AU - Koenig, M. K. AU - Butler, I. J. AU - Northrup, H. PY - 2008 DA - 2008// TI - Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex JO - J Child Neurol VL - 23 UR - https://doi.org/10.1177/0883073808321764 DO - 10.1177/0883073808321764 ID - Koenig2008 ER - TY - JOUR AU - Sparagana, S. P. AU - Wilkes, D. C. AU - Thompson, C. E. AU - Bowers, D. C. PY - 2010 DA - 2010// TI - Optic nerve tumor in tuberous sclerosis complex is not responsive to sirolimus JO - Pediatr Neurol VL - 42 UR - https://doi.org/10.1016/j.pediatrneurol.2010.01.016 DO - 10.1016/j.pediatrneurol.2010.01.016 ID - Sparagana2010 ER - TY - JOUR AU - Yalon, M. AU - Ben-Sira, L. AU - Constantini, S. AU - Toren, A. PY - 2011 DA - 2011// TI - Regression of subependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex JO - Childs Nerv Syst VL - 27 UR - https://doi.org/10.1007/s00381-010-1222-y DO - 10.1007/s00381-010-1222-y ID - Yalon2011 ER - TY - JOUR AU - Franz, D. N. AU - Leonard, J. AU - Tudor, C. AU - Chuck, G. AU - Care, M. AU - Sethuraman, G. PY - 2006 DA - 2006// TI - Rapamycin causes regression of astrocytomas in tuberous sclerosis complex JO - Ann Neurol VL - 59 UR - https://doi.org/10.1002/ana.20784 DO - 10.1002/ana.20784 ID - Franz2006 ER - TY - JOUR AU - Birca, A. AU - Mercier, C. AU - Major, P. PY - 2010 DA - 2010// TI - Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex JO - J Neurosurg Pediatr VL - 6 UR - https://doi.org/10.3171/2010.7.PEDS10221 DO - 10.3171/2010.7.PEDS10221 ID - Birca2010 ER - TY - JOUR AU - Lam, C. AU - Bouffet, E. AU - Tabori, U. AU - Mabbott, D. AU - Taylor, M. AU - Bartels, U. PY - 2010 DA - 2010// TI - Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors JO - Pediatr Blood Cancer VL - 54 UR - https://doi.org/10.1002/pbc.22298 DO - 10.1002/pbc.22298 ID - Lam2010 ER - TY - JOUR AU - Wienecke, R. AU - Fackler, I. AU - Linsenmaier, U. AU - Mayer, K. AU - Licht, T. AU - Kretzler, M. PY - 2006 DA - 2006// TI - Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex JO - Am J Kidney Dis VL - 48 UR - https://doi.org/10.1053/j.ajkd.2006.05.018 DO - 10.1053/j.ajkd.2006.05.018 ID - Wienecke2006 ER - TY - JOUR AU - Cabrera Lopez, C. AU - Marti, T. AU - Catala, V. AU - Torres, F. AU - Mateu, S. AU - Ballarin Castan, J. PY - 2011 DA - 2011// TI - Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosis JO - Nefrologia VL - 31 ID - Cabrera Lopez2011 ER - TY - JOUR AU - Dabora, S. L. AU - Franz, D. N. AU - Ashwal, S. AU - Sagalowsky, A. AU - DiMario, F. J. AU - Miles, D. PY - 2011 DA - 2011// TI - Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0023379 DO - 10.1371/journal.pone.0023379 ID - Dabora2011 ER - TY - JOUR AU - Davies, D. M. AU - Vries, P. J. AU - Johnson, S. R. AU - McCartney, D. L. AU - Cox, J. A. AU - Serra, A. L. PY - 2011 DA - 2011// TI - Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0445 DO - 10.1158/1078-0432.CCR-11-0445 ID - Davies2011 ER - TY - JOUR AU - Krueger, D. A. AU - Care, M. M. AU - Holland, K. AU - Agricola, K. AU - Tudor, C. AU - Mangeshkar, P. PY - 2010 DA - 2010// TI - Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1001671 DO - 10.1056/NEJMoa1001671 ID - Krueger2010 ER - TY - JOUR AU - Simon, R. PY - 1989 DA - 1989// TI - Optimal two-stage designs for phase II clinical trials JO - Control Clin Trials VL - 10 UR - https://doi.org/10.1016/0197-2456(89)90015-9 DO - 10.1016/0197-2456(89)90015-9 ID - Simon1989 ER - TY - JOUR AU - Truchuelo, T. AU - Diaz-Ley, B. AU - Rios, L. AU - Alcantara, J. AU - Jaen, P. PY - 2012 DA - 2012// TI - Facial angiofibromas treated with topical rapamycin: an excellent choice with fast response JO - Dermatol Online J VL - 18 ID - Truchuelo2012 ER - TY - JOUR AU - Wataya-Kaneda, M. AU - Tanaka, M. AU - Nakamura, A. AU - Matsumoto, S. AU - Katayama, I. PY - 2012 DA - 2012// TI - A novel application of topical rapamycin formulation, an inhibitor of mTOR, for patients with hypomelanotic macules in tuberous sclerosis complex JO - Arch Dermatol VL - 148 UR - https://doi.org/10.1001/archderm.148.1.138 DO - 10.1001/archderm.148.1.138 ID - Wataya-Kaneda2012 ER - TY - JOUR AU - Wheless, J. W. AU - Almoazen, H. PY - 2013 DA - 2013// TI - A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex JO - J Child Neurol VL - 28 UR - https://doi.org/10.1177/0883073813488664 DO - 10.1177/0883073813488664 ID - Wheless2013 ER - TY - JOUR AU - Foster, R. S. AU - Bint, L. J. AU - Halbert, A. R. PY - 2012 DA - 2012// TI - Topical 0.1 % rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients JO - Australas J Dermatol VL - 53 UR - https://doi.org/10.1111/j.1440-0960.2011.00837.x DO - 10.1111/j.1440-0960.2011.00837.x ID - Foster2012 ER - TY - STD TI - Krueger DA, Wilfong AA, Holland-Bouley K, Anderson AE, Agricola K, Tudor C et al. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol 2013. doi:10.1002/ana.23960. ID - ref57 ER - TY - STD TI - Canpolat M, Per H, Gumus H, Yikilmaz A, Unal E, Patiroglu T et al. Rapamycin has a beneficial effect on controlling epilepsy in children with tuberous sclerosis complex: results of 7 children from a cohort of 86. Childs Nerv Syst 2013. doi:10.1007/s00381-013-2185-6. ID - ref58 ER - TY - JOUR AU - Tiberio, D. AU - Franz, D. N. AU - Phillips, J. R. PY - 2011 DA - 2011// TI - Regression of a cardiac rhabdomyoma in a patient receiving everolimus JO - Pediatrics VL - 127 UR - https://doi.org/10.1542/peds.2010-2910 DO - 10.1542/peds.2010-2910 ID - Tiberio2011 ER - TY - JOUR AU - Pressey, J. G. AU - Wright, J. M. AU - Geller, J. I. AU - Joseph, D. B. AU - Pressey, C. S. AU - Kelly, D. R. PY - 2010 DA - 2010// TI - Sirolimus therapy for fibromatosis and multifocal renal cell carcinoma in a child with tuberous sclerosis complex JO - Pediatr Blood Cancer VL - 54 ID - Pressey2010 ER - TY - JOUR AU - Franz, D. N. AU - Belousova, E. AU - Sparagana, S. AU - Bebin, E. M. AU - Frost, M. AU - Kuperman, R. PY - 2013 DA - 2013// TI - Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(12)61134-9 DO - 10.1016/S0140-6736(12)61134-9 ID - Franz2013 ER - TY - JOUR AU - Bissler, J. J. AU - Kingswood, J. C. AU - Radzikowska, E. AU - Zonnenberg, B. A. AU - Frost, M. AU - Belousova, E. PY - 2013 DA - 2013// TI - Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(12)61767-X DO - 10.1016/S0140-6736(12)61767-X ID - Bissler2013 ER - TY - JOUR AU - Koenig, M. K. AU - Hebert, A. A. AU - Roberson, J. AU - Samuels, J. AU - Slopis, J. AU - Woerner, A. PY - 2012 DA - 2012// TI - Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin JO - Drugs R D VL - 12 UR - https://doi.org/10.2165/11634580-000000000-00000 DO - 10.2165/11634580-000000000-00000 ID - Koenig2012 ER -